BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23764908)

  • 1. Understanding the current status of image-guided ablation for metastatic colorectal disease.
    King AJ; Breen DJ
    Abdom Imaging; 2013 Dec; 38(6):1234-44. PubMed ID: 23764908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation of liver cancer.
    Lencioni R; Crocetti L
    Tech Vasc Interv Radiol; 2007 Mar; 10(1):38-46. PubMed ID: 17980317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous image-guided radiofrequency ablation of liver tumors.
    Lencioni R; Crocetti L; Pina MC; Cioni D
    Abdom Imaging; 2009; 34(5):547-56. PubMed ID: 19030918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors.
    Gervais DA; Goldberg SN; Brown DB; Soulen MC; Millward SF; Rajan DK;
    J Vasc Interv Radiol; 2009 Jan; 20(1):3-8. PubMed ID: 18948025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locoregional strategies for colorectal hepatic metastases.
    Meyers MO; Sasson AR; Sigurdson ER
    Clin Colorectal Cancer; 2003 May; 3(1):34-44. PubMed ID: 12777190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study.
    Ruers TJ; Joosten JJ; Wiering B; Langenhoff BS; Dekker HM; Wobbes T; Oyen WJ; Krabbe PF; Punt CJ
    Ann Surg Oncol; 2007 Mar; 14(3):1161-9. PubMed ID: 17195903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical treatment of hepatic metastases].
    Vallet C; Martinet O; Mosimann F
    Rev Med Suisse Romande; 2001 Feb; 121(2):119-24. PubMed ID: 11285691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiofrequency ablation of colorectal liver metastases].
    Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
    Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiofrequency ablation of colorectal metastases to the liver: results since the first application in the Netherlands].
    Blussé van Oud-Alblas M; Fioole B; Jansen MC; van Duijnhoven FH; van Hillegersberg R; Rijken AM; van Coevorden F; Borel Rinkes IH
    Ned Tijdschr Geneeskd; 2008 Apr; 152(15):880-6. PubMed ID: 18512529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises.
    Lencioni R; Crocetti L; Cioni D; Della Pina C; Bartolozzi C
    Invest Radiol; 2004 Nov; 39(11):689-97. PubMed ID: 15486530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?
    Mulier S; Ni Y; Jamart J; Michel L; Marchal G; Ruers T
    Ann Surg Oncol; 2008 Jan; 15(1):144-57. PubMed ID: 17906898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the Optimal Use of Ablation for Metastatic Colorectal Cancer to the Liver Without High-Level Evidence.
    Diaz-Nieto R; Fenwick S; Malik H; Poston G
    Curr Treat Options Oncol; 2017 Feb; 18(2):8. PubMed ID: 28214976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablative and catheter-directed therapies for colorectal liver and lung metastases.
    Petre EN; Sofocleous CT; Solomon SB
    Hematol Oncol Clin North Am; 2015 Feb; 29(1):117-33. PubMed ID: 25475575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases.
    Gillams AR; Lees WR
    J Vasc Interv Radiol; 2008 May; 19(5):712-7. PubMed ID: 18440460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resection and local therapy for liver metastases.
    Schlag PM; Benhidjeb T; Stroszczynski C
    Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):299-317. PubMed ID: 11969240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microwave ablation for liver tumors.
    Dou JP; Liang P; Yu J
    Abdom Radiol (NY); 2016 Apr; 41(4):650-8. PubMed ID: 26880177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatic metastasis of colorectal cancer--current therapeutic possibilities].
    Popescu I; Alexandrescu S
    Chirurgia (Bucur); 2010; 105(2):155-69. PubMed ID: 20540227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
    Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
    Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.